These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 21975030

  • 1. Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.
    Poli D, Antonucci E, Grifoni E, Paoletti O, Rancan E, Dentali F, Testa S.
    Thromb Res; 2012 May; 129(5):588-90. PubMed ID: 21975030
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, Hagiwara N.
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M, Själander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ.
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [Abstract] [Full Text] [Related]

  • 4. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [Abstract] [Full Text] [Related]

  • 5. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K, Sato M, Goto M, Saito A, Ikeda Y, Fujita S, Fuse K, Takahashi M, Oguro T, Matsushita H, Kitazawa H, Okabe M, Abe H, Toba K, Yamashina A, Aizawa Y.
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 7. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [Abstract] [Full Text] [Related]

  • 8. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GYH, Manning WJ.
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
    Abdelhafiz AH, Wheeldon NM.
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
    [Abstract] [Full Text] [Related]

  • 10. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E, Pizzuti A, Gandolfo N, Sclavo M, Tanga M, Riva G, Leonardi G, Bassignana A, Di Leo M.
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [Abstract] [Full Text] [Related]

  • 11. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Aug; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 12. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D, Antonucci E, Marcucci R, Fatini C, Alterini B, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D.
    Thromb Res; 2007 Aug; 121(3):347-52. PubMed ID: 17597186
    [Abstract] [Full Text] [Related]

  • 13. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 14. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    J Am Coll Cardiol; 2009 Sep 08; 54(11):999-1002. PubMed ID: 19729116
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulation and atrial fibrillation.
    Atwood JE, Albers GW.
    Herz; 1993 Feb 08; 18(1):27-38. PubMed ID: 8454250
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
    Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A.
    Am J Cardiol; 2017 Sep 01; 120(5):792-796. PubMed ID: 28709650
    [Abstract] [Full Text] [Related]

  • 17. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
    Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G, Italian Federation of Anticoagulation Clinics.
    Circulation; 2011 Aug 16; 124(7):824-9. PubMed ID: 21810658
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 May 16; 101(5):938-42. PubMed ID: 19404548
    [Abstract] [Full Text] [Related]

  • 19. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 20. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Circulation; 2012 May 15; 125(19):2298-307. PubMed ID: 22514252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.